Professional Documents
Culture Documents
Sample Case Presentation - Occult Bacteremia
Sample Case Presentation - Occult Bacteremia
Occult Bacteremia
5CLPH SG1 Armes, Janella V. Bagazin, Precious G.
Occult Bacteremia
Bacteremia s the presence of viable bacteria in the circulating blood.
Most episodes of occult bacteremia spontaneously resolve. Streptococcus pneumoniae and Salmonella, and serious sequelae are increasingly uncommon.
Occult Bacteremia
Patients with occult bacteremia by definition do not have clinical evidence other than fev
Occult bacteremia has been defined as bacteremia not associated with clinical evidence of sepsis or toxic appearance, underlying significant chronic medical conditions, or clear foci of infection upon examination in a patient.
Pathophysiology
Much of the pathophysiology of occult bacteremia is not fully understood.
Bacteria may be spontaneously cleared, they may establish a focal infection, or progress to septicemia
possible sequelae of septicemia include shock, disseminated intravascular coagulation, multiple organ failure, and death.
Risk Factors
Studies of the prevalence of bacteremia in children in diverse settings have identified no racial, geographic, or socioeconomic predisposition.
No sex-based difference in the prevalence or course of bacteremia is known. Studies of occult bacteremia focus on children younger than 3 years.
Patient Demographics
Age 4 y/o
FEVER
Sex Female
Weight 13.5kg
Pt CJS
Height 103 cm Admitted Jan 1, 2014 Allergy NKA
Final Diagnosis
Occult Bacteremia
persistence of fever with no dyspnea, hematuria, dysuria, abdominal pain and diarrhea noted.
due to persistence of fever patient sought consult to a local clinic . CBC and urinalysis were done advised admission. Due to financial constraints patient transferred to our institution.
HgB 111 Hct 0.33 WBC 17.08 N 0.81 L 0.18 E 0.01 platelet 378 yellow cloudy, pH 6.0 SG 1.020, Protein 0.3 g/dL Sugar (-) WBC 12-15/hpf RBC 1-3/ hpf Epithelial cell: few bacteria: moderate mucus threads: moderate
Patient Histories
PMH
Hospitalizations: none Operations: none Accidents: none Blood Transfusion: none Allergies/Drug Reactions: none
Patient Histories
Family History
(-) DM, HTN, Asthma, Allergies, Cancer, TB
Social History
patient lives with parents not exposed to cigar and air pollution
Medication History
Vital Signs
Temp 38.3 C
BP 100/60 mmHg
Vital Signs
RR 24 bpm
PR 120 bpm
Review of Systems
General Appearance HEENT Skin
(-) wt loss, (-) diaphoresis, (-) anorexia (-) blurring of vision, (-) deafness, () epistaxis, (-) bleeding gums, (-) sores (-) itchiness, (-) color change, (-) pigmentation, (-) rash
Review of Systems
Lungs
CardioVascular
Review of Systems
Abdomen
Extremities
Physical Examination
General Survey
HEENT
hair evenly distributed, no scalp lesions pink palpebral conjunctivae, anicteric sclera impacted cerumen AU (+) nasal discharge
Physical Examination
Skin Lungs
Symmetrical chest expansion, no retractions, equal vocal and tactile fremiti, resonant, normal breath sounds
Physical Examination
CardioVascular Abdomen
Adynamic precordium, (-) heaves, thrills, lifts, S1>S2 at apex, S2>S1 at base, Apex beat at 5th LICS MCL Soft and flabby abdomen, normoactive bowel sounds, tympanic, non-tender, no masses palpated
Physical Examination
Extremities
(-) Edema, (-) Cyanosis, no deformities, pulses full and equal
Neurological Exam
Cerebrum: conscious, coherent Cranial Nerves: CN I not assessed CN II pupils 2-3mm ERTL CN III, IV, VI full and equal extraocular movement CN V1-V3 no sensory deficits
Neurological Exam
CN VII can raise eyebrows, puff cheeks, smile, nonshallow nasolabial fold, symmetrical CN VIII gross hearing intact CN IX, X can swallow, intact gag reflex CN XI can shrug shoulders and turn head against resistance CN XII tongue midline in protrusion
Neurological Exam
Motor: 5/5 bilateral upper extremities Cerebellum: no ataxia, no dysdiadochokinesia Sensory: no deficits Reflexes: +2DTR on all extremities Meningeal Irritation: (-) Babinski, (-) nuchal rigidity
RBC
Hematocrit MCV
4.29x 106/L
0.34 78.20
3.6-5.2 x 106/L
0.28-0.46 76-100 fL
NORMAL
NORMAL NORMAL
MCH
MCHC RDW MPV PT WBC
26
33.20 12.50 IU/L 6.10 371 29.10
23-34 pg/cell
31.5 36.3 g/dL < 35 IU/L 6.4-10.4 fL 150-400 x 109/L 4.0-10.0 x 109/L
NORMAL
NORMAL NORMAL NORMAL NORMAL HIGH
UA
UA
Meds IVF: D5 0.3% NaCl 500 mL to run at 16-17 gtts/min (100%) Ampicillin-Sulbactam 500mg/ SIV infusion over 30 mins based on Ampicillin content (q6 hrs) (-) ANST; 148mg/kg/day
Labs -blood C/S -CBC with platelet -urinalysis -peripheral blood smear
Others Diet for AGE Monitor vital signs every 4 hours and record Monitor input and output every shift Watch out for vomiting, abdominal pain, and diarrhea
Meds Continue standing meds Paracetamol 120mg/5mL, give 6mL every 4 hours For temp > 38.3 degrees Celsius or as needed
Labs
Others:
Meds Continue standing meds IVF to follow: D5 0.3% NaCl 500mL to run at 16-17 gtts/min
Meds Hydrogen peroxide, instill 2-3 drops each 3x/day for 5 days D5 IMB 500mL to run at 1213gtts/min
Labs
Others:
Meds Ampicillin-Sulbactam 500mg/ SIVP shifted Co-amoxiclav 457mg/ 5mL, 3mL every 12 hours
Labs
Others:
Take Home Meds Co-amoxiclav 457mg/5mL, 3mL every 12 hours Hydrogen peroxide 2-3 drops each ear 3x a day for 7 days
Labs
Others:
List of Problems
1. Fever 2. Occult Bacteremia 3. Impacted Cerumen
Medications
Standing Meds
Ampicillin-Sulbtactam 500mg/ SIV q6h Hydrogen Peroxide 2-3 drops each 3x/day for 5 days Co-Amoxiclav 457mg/ 5mL, 3mL every 12 hours PRN Meds
Paracetamol 120mg/5mL, give 6mL every 4 hours PRN if Temp > 37.5
Fever
Pharmacotherapeutic Goals
Normalize body temperature Treatment of occult bacteremia Removal of impacted cerumen
Actual Management
Recommendations/ Intervention
S
N/A
Unclear dosing regimen/duration. Children and who are afebrile and well appearing can be treated on an ambulatory basis with a 10-day course of oral penicillin.
Suggest to physician the duration of Co-amoxiclav therapy is 10 days. Reference: NICE clinical guidelines
Actual Management
Recommendations/ Intervention
S
N/A
Suggest to physician to increase the dose of Co-amoxiclav therapy up to 4.2 mL or 4mL. Reference: NICE clinical guidelines
Recommendations/ Intervention
Based on amoxicillin content 13.5kgx25mg/kg= 337.5mg 400mg/5mL=x/3mL x=240 mg 337.5mg/x=400mg/5mL x=4.2mL
References:
Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. Jul 1993;22(7):1198-210 Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics. Jul 1997;100(1):128-34 Medscape.com Medline.com Lexicomp MIMS
Thank you!